Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)

NCT01643928 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

185

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: Rituximab-Pfizer (PF-05280586) x 3 courses
BIOLOGICAL: Rituximab-EU+ Rituximab-Pfizer x 2 Courses
BIOLOGICAL: Rituximab-US + Rituximab-Pfizer x 2 Courses

Sponsor

Pfizer